We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guide for overseas investors on how to access NHS procurement channels.
The home of Life Sciences Organisation on GOV.UK. We help UK life sciences companies to do business overseas and support foreign life sciences companies to invest in the UK.
We help UK life sciences companies to do business overseas and support foreign life sciences companies to invest in the UK.
Overview of the UK's cancer research infrastructure and the advantages of investing in the UK's life science sector to develop new treatments.
Overview of organisations supporting life sciences in the UK, organised by sub-sector and stage of product or service development.
Overview of the UK's antimicrobial resistance (AMR) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.
Minister Fairhead promotes Britain's life sciences at ABPI conference, setting out how the new export strategy will help support UK based businesses.
First published during the 2016 to 2019 May Conservative government
The second Life Sciences Sector Deal will support healthcare innovation and back businesses to create high-paid, high-quality jobs.
Overview of the UK's infectious diseases diagnostics (IDD) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's cell and gene therapy research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's orthopaedics research infrastructure and advantages of investment in the UK's life science sector to support new treatments and technology.
Overview of UK research infrastructure to develop new medical technology and advantages of investment in the UK's life science sector to support new products.
The government will today host the second in a series of roundtables with stakeholders from leading life science businesses.
Dr Liam Fox opinion editorial in the Sunday Telegraph on how the UK is leading innovation and technological change in the life sciences sector.
Overview of the UK's medical imaging infrastructure and advantages of investment in the UK's life science sector to develop new technology.
Welsh Secretary: “Investment is a real vote of confidence in Wales’ growing stature as a hotbed of life sciences expertise".
Overview of the UK's advanced wound-care research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Twenty one life sciences companies will join DIT on a trade mission to the world-renowned conference in Boston today.
Overview of UK research infrastructure for genomics technologies, and advantages of investment in the UK's life science sector to support new products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).